Matches in Wikidata for { <http://www.wikidata.org/entity/Q44717852> ?p ?o ?g. }
- Q44717852 description "2004 nî lūn-bûn" @default.
- Q44717852 description "2004年の論文" @default.
- Q44717852 description "2004年学术文章" @default.
- Q44717852 description "2004年学术文章" @default.
- Q44717852 description "2004年学术文章" @default.
- Q44717852 description "2004年学术文章" @default.
- Q44717852 description "2004年学术文章" @default.
- Q44717852 description "2004年學術文章" @default.
- Q44717852 description "2004年學術文章" @default.
- Q44717852 description "2004年學術文章" @default.
- Q44717852 description "2004年學術文章" @default.
- Q44717852 description "2004年學術文章" @default.
- Q44717852 description "2004年學術文章" @default.
- Q44717852 description "2004년 논문" @default.
- Q44717852 description "article científic" @default.
- Q44717852 description "article scientific" @default.
- Q44717852 description "article scientifique (publié 2004)" @default.
- Q44717852 description "articol științific" @default.
- Q44717852 description "articolo scientifico" @default.
- Q44717852 description "artigo científico (publicado na 2004)" @default.
- Q44717852 description "artigo científico (publicado na 2004)" @default.
- Q44717852 description "artigo científico" @default.
- Q44717852 description "artikull shkencor" @default.
- Q44717852 description "artikulong pang-agham" @default.
- Q44717852 description "artykuł naukowy" @default.
- Q44717852 description "artículo científico publicado en 2004" @default.
- Q44717852 description "artículu científicu" @default.
- Q44717852 description "bilimsel makale" @default.
- Q44717852 description "bài báo khoa học" @default.
- Q44717852 description "mokslinis straipsnis" @default.
- Q44717852 description "naučni članak" @default.
- Q44717852 description "scienca artikolo" @default.
- Q44717852 description "scientific article" @default.
- Q44717852 description "teaduslik artikkel" @default.
- Q44717852 description "tieteellinen artikkeli" @default.
- Q44717852 description "tudományos cikk" @default.
- Q44717852 description "vedecký článok" @default.
- Q44717852 description "vetenskaplig artikel" @default.
- Q44717852 description "videnskabelig artikel (udgivet 2004)" @default.
- Q44717852 description "vitenskapelig artikkel" @default.
- Q44717852 description "vitskapeleg artikkel" @default.
- Q44717852 description "vědecký článek" @default.
- Q44717852 description "wetenschappelijk artikel" @default.
- Q44717852 description "wissenschaftlicher Artikel" @default.
- Q44717852 description "επιστημονικό άρθρο" @default.
- Q44717852 description "мақолаи илмӣ" @default.
- Q44717852 description "мақолаи илмӣ" @default.
- Q44717852 description "наукова стаття, опублікована в лютому 2004" @default.
- Q44717852 description "научна статия" @default.
- Q44717852 description "научная статья" @default.
- Q44717852 description "научни чланак" @default.
- Q44717852 description "научни чланак" @default.
- Q44717852 description "գիտական հոդված" @default.
- Q44717852 description "מאמר מדעי" @default.
- Q44717852 description "سائنسی مضمون" @default.
- Q44717852 description "مقالة علمية" @default.
- Q44717852 description "مقالهٔ علمی" @default.
- Q44717852 description "২০০৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q44717852 description "บทความทางวิทยาศาสตร์" @default.
- Q44717852 description "სამეცნიერო სტატია" @default.
- Q44717852 name "Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: a prospective, placebo-controlled assessment." @default.
- Q44717852 name "Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: a prospective, placebo-controlled assessment." @default.
- Q44717852 type Item @default.
- Q44717852 label "Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: a prospective, placebo-controlled assessment." @default.
- Q44717852 label "Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: a prospective, placebo-controlled assessment." @default.
- Q44717852 prefLabel "Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: a prospective, placebo-controlled assessment." @default.
- Q44717852 prefLabel "Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: a prospective, placebo-controlled assessment." @default.
- Q44717852 P1433 Q44717852-77929754-A108-4287-A765-A4FF3FD589C1 @default.
- Q44717852 P1476 Q44717852-078A4DB1-D707-422D-A3D1-14AA2BFFFC62 @default.
- Q44717852 P2093 Q44717852-14AD694A-8413-44B2-9ED2-05B68EFC0F33 @default.
- Q44717852 P2093 Q44717852-1D115519-05E7-45B2-B4D5-81F1DC335EA6 @default.
- Q44717852 P2093 Q44717852-28E3E85E-D8F4-41F9-A0AA-CD9EB1108E9C @default.
- Q44717852 P2093 Q44717852-38BEEEEF-3533-47DA-848D-49152EC7BECE @default.
- Q44717852 P2093 Q44717852-85051ED6-E4AC-4A56-9AA8-5FF7381FF14F @default.
- Q44717852 P2093 Q44717852-B1CCA943-07B8-4BB0-B927-5B31657B3FDF @default.
- Q44717852 P2093 Q44717852-B3C909BE-78D7-481D-A093-D23C2C36BF46 @default.
- Q44717852 P2093 Q44717852-C3E3166E-47FA-4AA7-8A5F-55B32DC21BE5 @default.
- Q44717852 P2093 Q44717852-C8D40610-B932-4990-BCEC-38EFFB7444A8 @default.
- Q44717852 P2093 Q44717852-EEEE265B-3807-497E-AB29-7231D21AACE7 @default.
- Q44717852 P304 Q44717852-BEE2C52D-5F49-489A-9A55-5D8D4E6DFC05 @default.
- Q44717852 P31 Q44717852-5533643B-D63E-46D2-9A66-E87D61A54E84 @default.
- Q44717852 P356 Q44717852-6C429234-A29E-47E6-83C6-A587B9ADAF24 @default.
- Q44717852 P407 Q44717852-53CC8B02-CB85-489B-8584-FBB3E2457B3B @default.
- Q44717852 P433 Q44717852-C3D98E42-59F4-46D6-9693-D6243E8A2777 @default.
- Q44717852 P478 Q44717852-FA9122B8-FF7F-4AB7-983F-F59A76533B62 @default.
- Q44717852 P50 Q44717852-9AE6A741-8DB8-44BB-988B-A4D00A262FB4 @default.
- Q44717852 P577 Q44717852-F9ED84D4-1705-412D-B6DE-A7F94E130F05 @default.
- Q44717852 P698 Q44717852-B6CE8D82-7C44-4E4B-A6C2-887812A415C0 @default.
- Q44717852 P921 Q44717852-2DC61128-AE07-490A-9940-E38FB5FBE7F2 @default.
- Q44717852 P921 Q44717852-6701CFB5-ED1F-49A7-BFF7-CBDF177ADE70 @default.
- Q44717852 P921 Q44717852-9228127D-C1E3-4913-A9CE-3D72CC373EF2 @default.
- Q44717852 P921 Q44717852-BD431E09-60F2-4A88-A8B3-9E76B92CB0F3 @default.
- Q44717852 P356 01.JCP.0000104907.75206.C2 @default.
- Q44717852 P698 14709944 @default.
- Q44717852 P1433 Q6294969 @default.
- Q44717852 P1476 "Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: a prospective, placebo-controlled assessment" @default.
- Q44717852 P2093 "Albert J Allen" @default.
- Q44717852 P2093 "David Michelson" @default.
- Q44717852 P2093 "Denái Milton" @default.
- Q44717852 P2093 "Douglas Kelsey" @default.